In addition to retrospective studies, Dr. Lee is currently co-investigator on a recently funded R21 with Dr. Susan Vadaparampil which seeks to improve genetic counseling services for patients recently diagnosed with breast cancer. She also is actively involved with her colleagues in investigating and improving fertility preservation education for providers and patients; these efforts have resulted in accepted abstracts to the ASCO 2012 National Meeting and the American Society for Reproductive Medicine. She also is collaborating with the faculty in Molecular and Functional Imaging in the development of novel agents for intraoperative identification of breast cancer. And finally, she is the primary investigator for two ongoing clinical trials, one investigator-initiated project examining 3D ultrasound for breast cancer patients, and another industry-sponsored phase 0 trial examining novel agents in breast cancer. Her other research focus is primarily translational; she has had one grant-funded project examining early biomarkers for breast cancer and continues to actively seek external funding for this and other translational projects.